Blog Posts

Aug 1, 2025, 20:38

Mark Yarchoan: More Disappointing News in Hepatocellular Carcinoma

Mark Yarchoan, Associate Professor at Johns Hopkins Hospital, shared a recent article by him and colleagues on X:

“More disappointing news in HCC: Adjuvant pembrolizumab failed to beat surveillance in the global P3 KEYNOTE-937 trial (NCT03867084). Merck disclosed the negative result quietly in an SEC filing. Not unexpected after IMbrave050.”

Mark Yarchoan

More posts featuring Mark Yarchoan.

cancer hepatocellular carcinoma Mark Yarchoan OncoDaily Oncology

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Insight

Aug 21, 2025, 11:16

Kefah Mokbel: TAD Proven Safe with Effective Long-Term Outcomes for Breast Cancer Patients

Voices

Aug 21, 2025, 11:15

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

OncoDaily Pulse

Aug 21, 2025, 10:23

Archana Ajmera: Meet the Experts of VIRO 2025

OncoDaily Pulse

Aug 21, 2025, 10:08

Yüksel Ürün: Meet the Experts of VIRO 2025

Voices

Aug 21, 2025, 09:46

Pratiti Bandopadhayay: Urgent Need to Sustain Funding for Pediatric Brain Tumor Trials

Voices

Aug 21, 2025, 09:30

Jana Ellegast: Inflammatory Signaling in the Pathogenesis of AML

Insight

Aug 21, 2025, 09:02

Humaid Al-Shamsi: Outcomes of HSCT from Matched Related Donors in Pediatric Patients

Celebrities

Aug 21, 2025, 08:40

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Insight

Aug 21, 2025, 08:17

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

Science

Aug 21, 2025, 06:29

Moazzam Shahzad: The Impact of MRD Status after Matched Donor alloHCT in AML

Insight

Aug 21, 2025, 00:36

Tom Powles: IMVIGOR011 Trial Brings ctDNA-Guided Adjuvant Immunotherapy to Bladder Cancer

Voices

Aug 21, 2025, 00:00

Kristina Lindemann: Advancing Gynecological Cancer Trials with ENGOT in Norway